Table 1.
Comparisons Across Pharmacological Classes of Antidepressant Medications Prescribed to the Study Patients. The Numbers of Patients Prescribed a Medication in Each Pharmacological Class and the Particular Medications in Each Pharmacological Class
| Pharmacological Class of Antidepressants | Medication Name | Number of Patients (%)§ Using the Medication During the Study Period |
|---|---|---|
| SSRI | 59 (60.8%) | |
| Escitalopram | 8 | |
| Fluoxetine | 13 | |
| Fluvoxamine | 3 | |
| Paroxetine | 17 | |
| Sertraline | 29 | |
| SNRI | 44 (45.4%) | |
| Duloxetine | 15 | |
| Venlafaxine | 33 | |
| TCA | 5 (5.2%) | |
| Doxepin | 1 | |
| Imipramine | 4 | |
| SARI | 4 (4.1%) | |
| Trazodone | 4 | |
| RIMA | 2 (2.1%) | |
| Moclobemide | 2 | |
| NDRI | 17 (17.5%) | |
| Bupropion | 17 | |
| NaSSA | 18 (18.6%) | |
| Mirtazapine | 18 |
Note: §patients may be prescribed with more than one antidepressant.
Abbreviations: SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin-norepinephrine reuptake inhibitor; TCA, tricyclic antidepressant; SARI, serotonin-2 antagonist reuptake inhibitor; RIMA, reversible inhibitor of monoamine oxidase-A (MAO-A); NDRI, noradrenergic-dopamine reuptake inhibitor; NaSSA, noradrenergic-specific serotonergic antidepressants.